Orchid Pharma Limited (NSE:ORCHPHARMA)

Orchid Pharma Statistics

Total Valuation

Orchid Pharma has a market cap or net worth of INR 34.92 billion. The enterprise value is 36.25 billion.

Market Cap	34.92B
Enterprise Value	36.25B

Important Dates

The next estimated earnings date is Monday, February 9, 2026.

Earnings Date	Feb 9, 2026
Ex-Dividend Date	n/a

Share Statistics

Orchid Pharma has 50.72 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	50.72M
Shares Outstanding	50.72M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.13%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	23.63%
Float	15.30M

Valuation Ratios

The trailing PE ratio is 66.65 and the forward PE ratio is 33.06.

PE Ratio	66.65
Forward PE	33.06
PS Ratio	4.25
PB Ratio	2.74
P/TBV Ratio	2.77
P/FCF Ratio	n/a
P/OCF Ratio	76.15
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 53.70, with an EV/FCF ratio of -16.32.

EV / Earnings	69.17
EV / Sales	4.41
EV / EBITDA	53.70
EV / EBIT	111.08
EV / FCF	-16.32

Financial Position

The company has a current ratio of 3.35, with a Debt / Equity ratio of 0.22.

Current Ratio	3.35
Quick Ratio	1.67
Debt / Equity	0.22
Debt / EBITDA	4.19
Debt / FCF	-1.27
Interest Coverage	2.20

Financial Efficiency

Return on equity (ROE) is 4.20% and return on invested capital (ROIC) is 2.42%.

Return on Equity (ROE)	4.20%
Return on Assets (ROA)	1.20%
Return on Invested Capital (ROIC)	2.42%
Return on Capital Employed (ROCE)	2.14%
Weighted Average Cost of Capital (WACC)	6.53%
Revenue Per Employee	11.16M
Profits Per Employee	712,024
Employee Count	736
Asset Turnover	0.49
Inventory Turnover	1.65

Taxes

Income Tax	-1.88M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.91% in the last 52 weeks. The beta is 0.45, so Orchid Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	-54.91%
50-Day Moving Average	797.78
200-Day Moving Average	755.66
Relative Strength Index (RSI)	32.22
Average Volume (20 Days)	59,323

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orchid Pharma had revenue of INR 8.21 billion and earned 524.05 million in profits. Earnings per share was 10.33.

Revenue	8.21B
Gross Profit	3.04B
Operating Income	323.33M
Pretax Income	522.17M
Net Income	524.05M
EBITDA	668.62M
EBIT	323.33M
Earnings Per Share (EPS)	10.33

Balance Sheet

The company has 1.49 billion in cash and 2.82 billion in debt, with a net cash position of -1.33 billion or -26.24 per share.

Cash & Cash Equivalents	1.49B
Total Debt	2.82B
Net Cash	-1.33B
Net Cash Per Share	-26.24
Equity (Book Value)	12.74B
Book Value Per Share	251.49
Working Capital	4.95B

Cash Flow

In the last 12 months, operating cash flow was 458.52 million and capital expenditures -2.68 billion, giving a free cash flow of -2.22 billion.

Operating Cash Flow	458.52M
Capital Expenditures	-2.68B
Free Cash Flow	-2.22B
FCF Per Share	-43.80

Margins

Gross margin is 37.03%, with operating and profit margins of 3.94% and 6.38%.

Gross Margin	37.03%
Operating Margin	3.94%
Pretax Margin	6.36%
Profit Margin	6.38%
EBITDA Margin	8.14%
EBIT Margin	3.94%
FCF Margin	n/a

Dividends & Yields

Orchid Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	1.50%
FCF Yield	-6.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4